The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for KS Lam


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrinavß3.EBI
University of California
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.EBI
University of California
Novel flavonoids with antiproliferative activities against breast cancer cells.EBI
University of California Davis
Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.EBI
University of California Davis
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.EBI
University of California
Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.EBI
University of California
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.EBI
University of Arizona
Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics.EBI
The Bristol-Myers Squibb Pharmaceutical Research Institute
Indole substituted pyrrolopyrimidinyl inhibitors of Uba6BDB
Millennium Pharmaceuticals
Fused heterocyclic compounds as CaM kinase inhibitorsBDB
Gilead Sciences